ArticleAIDS (London, England)2018

Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection.

Lorna Leal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.